India-US Trade Negotiations: Why Experts Warn Against Locking Into a Lopsided Deal Under Section 301 Pressure
Trade experts have cautioned against India accepting an interim bilateral trade agreement with the United States that may be weighted heavily in Washington's favour, under pressure from threatened US Section 301 investigations.
The US and India announced a framework for an interim Bilateral Trade Agreement (BTA) in February 2026, reducing the US reciprocal tariff on Indian goods from 25% to 18%.
Washington has simultaneously initiated Section 301 investigations (March 2026) targeting structural excess manufacturing capacity in multiple countries, including India, citing a US$58 billion trade surplus India ran with the US in 2025.
India was also placed on the Priority Watch List in the 2026 USTR Special 301 Report on intellectual property (IP) protection and enforcement.
Experts warn that locking in at 18% tariffs does not guarantee immunity from future US protectionist measures — additional tariff threats (such as Section 301 actions) can be layered on separately regardless of the BTA.
Section 301 of the US Trade Act of 1974
Section 301 is a provision of the United States Trade Act of 1974 that grants the US Trade Representative (USTR) broad authority to investigate and respond to foreign government trade practices deemed "unreasonable," "discriminatory," or that "burden or restrict US commerce." Actions under Section 301 can lead to retaliatory tariffs, import restrictions, or other trade penalties.
The threat of Section 301 action on excess capacity — even as the bilateral tariff deal sets a baseline of 18% — shows that a negotiated tariff rate does not insulate India from additional protectionist measures. Experts argue this makes the 18% "lock-in" a weak shield against future US trade pressure.
India-US Bilateral Trade Architecture
The India-US trade relationship is the largest bilateral goods and services trade partnership for India. India ran a merchandise trade surplus of approximately US$58 billion with the US in 2025, making it one of Washington's largest deficit relationships. The interim BTA framework signed in February 2026 included:
Experts argue that signing a comprehensive BTA under duress from Section 301 threats means India is negotiating from a position of weakness, potentially making asymmetric concessions — such as opening sensitive sectors or accepting unfavourable IP norms — that disproportionately benefit US interests.
WTO Dispute Settlement and Unilateral Tariff Actions
Section 301 actions are unilateral US measures that have been repeatedly found incompatible with WTO obligations. The WTO Dispute Settlement Body ruled in 2019 that the US Section 301 tariffs on Chinese goods violated WTO rules (DS543). However, the WTO Appellate Body has been non-functional since December 2019 due to US blocking of new appointments — effectively neutering the enforcement mechanism.
Key Details
- WTO Appellate Body has been paralysed since December 2019; appeals are lodged but cannot be heard.
- India and 26 other WTO members joined the Multi-Party Interim Appeal Arbitration Arrangement (MPIA) as an alternative appellate mechanism.
- Without a functional WTO Appellate Body, unilateral Section 301 measures face no credible multilateral check.
- India challenged several US tariff actions at WTO (e.g., steel/aluminium under DS518) with limited enforceability.
The weakening of multilateral trade dispute mechanisms leaves countries like India with limited recourse when faced with US unilateral trade pressure. Bilateral deals negotiated under duress in this environment risk codifying asymmetric obligations.
India's Tariff Policy and Sensitive Sectors
India's average applied tariff rate (~12%) is significantly higher than the US (~3.3%) and most developed economies, reflecting its use of tariffs as an industrial policy instrument. Sectors India has historically protected include: agriculture, dairy, automobiles, electronics, and pharmaceuticals. Commitments under a BTA to "eliminate or reduce tariffs on all US goods" risk opening these sectors to competitive pressure before domestic industries are globally competitive.
Key Details
- India's simple mean applied MFN tariff: ~12% (WTO, 2024); US: ~3.3%.
- Sensitive sectors for India in trade negotiations: dairy (US dairy lobby vs Indian cooperatives like Amul), poultry, agriculture, pharmaceuticals (data exclusivity vs compulsory licensing).
- India's patent regime under the Patents Act, 1970 (as amended in 2005) — particularly Section 3(d) limiting evergreening — is a recurring friction point with the US pharma industry.
- Data localisation requirements and e-commerce market access rules are additional non-tariff barriers the US seeks to address.
Experts' core concern is that Section 301 threat creates negotiating pressure on India to make pre-emptive concessions on these sensitive sectors without securing equivalent market-access gains in services (where India has competitive advantage, e.g., IT, skilled professionals).
- India's trade surplus with US in 2025: ~US$58 billion
- US reciprocal tariff on India: reduced from 25% to 18% under the February 2026 interim framework
- Section 301 investigations on excess manufacturing capacity initiated: March 2026 (16 economies including India)
- India placed on USTR Special 301 Priority Watch List: 2026 report
- India formally rejected Section 301 excess-capacity allegations: April 2026
- India's commitment under interim BTA: US$500 billion in US product purchases over 5 years
- India's average applied MFN tariff: ~12% vs US ~3.3%
- WTO Appellate Body non-functional since: December 2019
- Key Indian exports at risk: pharmaceuticals, textiles, gems and jewellery, automobiles, IT services
- India is the US's 8th largest trading partner (goods); US is India's largest goods export destination